Pharmafile Logo
Pharmafocus logo
Advanced Search

UCART19

Showing 1 posts of 1 posts found.

Servier signs leukaemia deal

February 19, 2014
Research and Development, Sales and Marketing Servier, UCART19, car, cellectis, leaukaemia

French firms Servier and small biopharma cancer specialist Cellectis have signed a deal to develop and commercialise one drug targeting …

News
The Gateway to Local Adoption Series

Latest content

InnoScot highlights NHS Scotland’s progress towards net zero healthcare

August 11, 2026

NHS England approves delayed-release treatment for rare kidney disease

August 10, 2026

Product value to pathway impact: What the CVD Modern Service Framework means for pharma

August 9, 2026

Functional lung imaging offers new possibilities for respiratory care

August 9, 2026

Five Facts about cardiovascular disease

August 9, 2026